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The  observation  that  viruses  may  exhibit  different  biological  properties 
when maintained  in different hosts is well established.  Because of its practical 
consequences  the  phenomenon  of reduced  virulence  has  been  the  subject  of 
numerous studies. However, owing to the complexity of host-virus interactions, 
basic information is still scanty (1), and it is mainly for this reason that use of 
attenuated  variants  for active immunization  has  been  greatly hampered,  the 
possibility  of reversion  to virulence  being  of great  concern.  The  more recent 
finding that polioviruses may become attenuated for their original primate host 
when passed in cells in vitro (2, 3) has once more stimulated attempts to obtain 
insight  into  the basic mechanisms governing the  appearance  and  selection  of 
attenuated variants. 
In spite of great efforts, study on polioviruses has progressed slowly, mainly 
owing to the high cost and difficulty in maintaining a  stock of monkeys large 
enough  to permit  work on a  sound quantitative  basis.  In looking for a  sub- 
stitute,  it was found that  Coxsackie viruses,  which are similar  to polioviruses 
in their biological and physical properties, lost pathogenicity for suckling mice 
when passed in cells in vitro (4). Thus a model became available permitting the 
study of attenuation  of enteroviruses much more economically than had been 
possible  so  far.  Experiments  designed  to  characterize  this  system  will  be 
presented. 
Materials and Methods 
Cell cultures.--Human amniotic membranes were treated  according to a standard  method 
recently  developed in our laboratory  (5). Growth medium consisted of Eagle's medium  (6) 
supplemented with 0.5 per cent lactalbtmain hydrolysate (LaH) and 10 per cent human serum 
(HuS).  Cells from Roux bottles  were seeded into cell culture  tubes  and square  screw cap 
bottles (7). Mter 24 to 72 hours cultures were rinsed 3 times and used for assay or virus multi- 
plication with maintenance medium containing yeast extract 0.05 per cent, LaH 0.25 per cent 
(prepared in water as 1 per cent and 5 per cent stock solutions, respectively), and calf serum 
(CaS) 10 per cent in Hanks's balanced salt solution (BSS) with additional NaHCO3 to give 
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a  final concentration of 0.11 per cent. Penicillin, streptomycin, and tetracycline were added 
to give 100 units, 100/zg. and 25/zg. per ml., respectively. Monkey kidney (MoK) cell cultures 
were prepared as described by Rappaport (8). Growth medium consisted of 0.5 per cent LaH 
in  BSS  with 5 per cent  CaS  (9).  After inoculation, ceils  were maintained under a  similar 
medium with CaS reduced to 1 to 2 per cent and NaHCO3  (added as a  1.4 per cent solution 
in water) increased to a final concentration of 0.14 per cent. 
Suckling Mice.--Litters  from Swiss albino mothers were used when 12 to 36 hours old. 
Viruses.--Coxsackie group A viruses had had a history of passages in newborn mice only. 
We are indebted to Dr. G. Dalldorf for strains "Belgium l"  (A-11), "Floras" (A-13), "G 14" 
(A-14), "G 9" (A-15), and "G 13" (A-18). From Dr. J. L. Melnick we received "Wiederhold" 
(A-9) and "Alaska" (A-10).  Pools of group A viruses were prepared in suckling mice.  After 
intraperitoneal injection of 0.05  ml. of mouse suspension containing 100 to  1000 LD~0  the 
animals were killed  with ether when extensive paralysis had developed. They were skinned, 
eviscerated, and ground with alundum in a  mortar. A  1:10 suspension (w/v) was prepared 
with BSS  containing 10  per cent inactivated CaS  and antibiotics. After centrifugation the 
supernate was stored in ampoules at --30°C. This virus source was considered 10  -1 for further 
calculations. When this study was initiated only Coxsackie  B  viruses, which had previously 
been passed in HeLa and MoK ceils, were available. "Connecticut-5" (B-I) had been passed 
17 times in HeLa and once in MoK cells before a working pool from MoK cell cultures was 
prepared. "Ohio 1"  (B-2) had had a history of 8 HeLa and 8 MoK passages, "Nancy" (B-3) 
of  12  HeLa passages, and "Powers" (B-4)  of 14 HeLa and 6 MoK passages before a  final 
MoK pool was prepared. "Faulkner"  (B-5) had been maintained in HeLa and MoK (3 and 
1 passages, respectively) prior to pool production. These viruses had come to our laboratory 
originally from Dr. A. B. Sabin (B-2 and B-4), Dr. J. L. Melnick (B-3), Dr. G. Dalldorf (B-5), 
and from the American Type Culture Collection (B-I). Pools from MoK cultures were pre- 
pared as follows:  monolayer cultures in  200  ml.  bottles were infected with  high  doses of 
virus. After almost  complete cell destruction, cells  and  medium were frozen and  thawed 
once, centrifuged, and  stored in ampoules at  -30°C. For calculations this material was con- 
sidered to be undiluted (10°C.). 
Through the kind help of Dr. J. L. Melnick, Dr. A. B. Sabin, and Dr. L. Rosen it later be- 
came possible to include the same Coxsackie group B strains without any cell culture history. 
Pools as l0 per cent mouse suspension  were prepared as with group A viruses, except that the 
intracerebral route of inoculation (0.02 ml.)  was employed. 
Passages.--For high concentration passages, between 100 and 10,000 TCID~0 were inocu- 
lated into tube cultures.  Mter extensive cytopathic effect (CPE)  had developed, cells  and 
medium were frozen and thawed once,  pooled, and used for further passage under similar 
conditions. For high dilution passages, cultures were infected as for titration. All tubes of the 
highest dilution showing CPE were frozen and thawed once and the pooled contents were 
used for the next passage. 
Back passages in mice were done at high concentration only. In the case of group A viruses 
0.05 ml. of a  10 per cent virus suspension was inoculated intraperitoneally into each of 6 to 8 
mice.  Animals were killed  when paralysis was extensive or by the 5th day if no symptoms 
developed. A 10 per cent suspension from at least 4 mice was prepared and used for further 
passage. The procedure for group B  viruses was essentially the same except that 0.02  ml. 
were inoculated intracerebrally and 0.05 ml. were inoculated intraperitoneaUy. 
Clonal Sdection of Viruses.--Although  most of the Coxsackie  viruses used in this study 
produced a  marked CPE on amnion cells under a  liquid medium, A-10,  A-11,  A-13,  A-14, 
A-15, and A-18 and B-2 and B-4 developed plaques under agar irregularly and of pin-point 
size only. Therefore, purification was attempted by limiting dilution procedure. 5 to 6 tubes 
per tenfold dilution step were inoculated. Cultures showing CPE were frozen at  --20°C. At 
the end of the observation period of 8 days the content of a  single tube from a  dilution at ~'.  LEH:MANN-GRUBE AND  .]'. T.  S~/VERTON  813 
least 1 step above the calculated TCIDs0 was used for further passages in the same manner. 
Since some of the Coxsackie viruses produce little CPE with low virus  concentrations  even 
after prolonged observation periods (10), end points are not always sharp and might well he 
underestimated. That this imposes serious limitations on purification procedures based on the 
limiting dilution principle is obvious. No other approach, however, was available. Types A-9 
and B-3 were also plaque-purified. Virus diluted in 0.5 log steps was spread on cell monolayers 
in square screw cap bottles. Mter 2 hours' adsorption, cultures were rinsed 3 times with 5 ml. 
BSS and overlaid with a medium containing 0.75 per cent agar. After 36 to 48 hours a second 
overlay with neutral red 1 : 10,000 was added.  Discrete plaques from bottles containing only 
1 to 3 plaques were picked with a bent pipette, transferred to 1 ml. BSS, and frozen and thawed 
once.  Mter  filtration through  a  membrane filter  (Mlllipore type  HA)  this  suspension  was 
again diluted and directly transferred onto new monolayers for further plaque passage. 
Virus Titrations.--6 tube cell cultures per tenfold serial dilution of virus were used. Virus 
was diluted in maintenance medium and inoculated in 1 ml. amounts into cultures. All final 
readings were done on the 9th day. Titrations in suckling mice were performed by inoculating 
0.05  ml. intraperitoneally or 0.02  ml. intracerebrally for group A and  B  virus respectively 
into at least 8 mice per tenfold dilution step.  All mice dead between the 4th and  14th  day 
were considered positive. The titers were calculated according to Behrens (11) and Reed and 
Muench (12), and expressed on a  1 ml., 0.05 ml., and 0.02 ml. basis for titrations done in cell 
cultures and mice, group A and group B, respectively. Passages in amnion cell cultures resulted 
in a marked attenuation of the viruses for mice, associated with a significant flattening of the 
dose-response curve. Accordingly attenuated  viruses were titrated  in  duplicate or triplicate 
to compensate for loss of accuracy. 
Virus Neutralization Tezts.--Monkey immune sera, previously prepared in our laboratory 
and tested by Dr. R. L. Crowell of this department, diluted 1: 20 in maintenance medium, were 
added to an equal volume of virus suspension diluted to contain approximately 200 TCID~0/ 
ml. Mter 1 hour of incubation at 37°C.,  1 ml. of this mixture was added to each of 6 tissue 
culture tubes. The final reading was done on the 9th day. Appropriate controls were included 
to ensure the correct amount of the challenging virus. 
Deflnitions.--"Adaptation" is used to indicate increase in titer and degree of cell destruction 
and a decrease in time of appearance of CPE in the course of passage of the virus in cell cul- 
tures.  "Attenuation" or "loss of virulence" denotes  decrease of pathogenicity of the virus 
for mice when control titrations in cell cultures fail to show a corresponding drop of titer. 
EXPERIMENTAL 
Adaptation  to  Human  Amnion  Cells  in  Primary  Culture.--From  the  24 
Coxsackie prototype  viruses  tested  in human  amnion  cells in vitro,  A-9, A-10, 
A-11,  A-13,  A-14,  A-15,  and  A-18 and  B-1  to  B-5  could  be passed  with  CPE 
(10).  Continuous high concentration passage of these 7 group A  and 5  group B 
strains  resulted in increase in infectious titer and proportion  of cells destroyed 
and a  decrease in time for the appearance of CPE. Although these observations 
were  unequivocal,  definite  conclusions  as  to  the  degree  of  adaptation  could 
not  be  drawn  from  the  results.  Therefore  an  experiment  was  done  in  which 
1st  and  10th  amnion  passage  viruses  were  compared  under  more  controlled 
conditions. 
Cultures  were prepared  from a  single placenta.  They were inoculated with the original 
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A-13, A-15, A-18, B-l, B-2, B-3, and B-5. An attempt was made to use equal infectious doses 
for both passage levels. The 10th passage  cultures showed cell destruction faster and more 
extensively than those of the 1st passage. This phenomenon  was particularly striking in the 
case of the group A viruses which will be considered first. Comparative titrations of the 1st 
and  10th passage pools prepared as described  were performed  using  tube cultures from  ! 
placenta. 
Results are shown in Table I. It can be seen that in all cases the 10th passage 
titers exceeded those of the 1st passages. The differences were marked in most 
cases and left no doubt as to their significance. Since A-10 and A-14 showed no 
CPE  with  1st  amnion  passage,  they  were  not  included  in  the  comparative 
TABLE I 
Titers in Amnion Cell Cultures and in Suckling Mice of Coxsackie A  Virus Strains, 
ist and lOth Amnion Passages 
Titer* of amnion virus in 
Coxsaekie type 
mice  amnion 
i 
Passage No  ..........  1  I  10 
A-9 
A-11 
A-13 
A-15 
A-18 
3.6  I 
3,7 
4.9 
5,4  ] 
2.9 
10  1 
3.4  6.8 
<1,0  2.5 
1.0  5.5 
<1.0  4.5 
2.0  5,7 
8.2 
5.7 
7.0 
5.5 
6.3 
Cultures from a single placenta were inoculated with original mouse virus and 9th amnion 
passage virus.  Comparative titrations of 1st and 10th passage pools thus obtained were per- 
formed in mice and in tube cultures from 1 amnion. 
* Negative log LDs0 per 0.05 ml. and TCIDso per 1 ml., respectively. 
assay just described. The extent of adaptation can, however, be assessed from 
Table  II  which  shows  significant increase of  infectious titers  with successive 
amnion passages. 
The  group  B  viruses showed  little,  if any,  adaptation  when  1st  and  10th 
amnion  passage  of viruses previously maintained  in  cell  cultures  were  com- 
pared by amnion cell assay. When reference is made to viruses without in vitro 
history, adaptation with continuous passages in cell cultures of primate origin 
appears to be very pronounced  (Table III). Only  the  "Nancy"  strain of B-3 
virus  exerted  extensive  cell  destruction  with  high  titers  from  the  beginning 
and did not change this property with passages in ceils. 
Attenuation  of Virulence for Newborn  Mice.--When  comparable virus prep- 
arations  from  2  separate  culture  passages  were  titrated  in  mice  it  was  seen 
that  the  gain in  infectivity for  ceils in  vitro  was  associated with  a  decreased 
pathogenicity for  mice  (Table  I).  Attenuation  was  most  obvious  with  types 
A-11 and A-15.  Here the  inoculation of more than  10,000  TCIDs0  caused  the TABLE  II 
Comparative Titrations  in Amnion Cell Cultures and in Suckling Mice of Coxsackie 
A  Viruses after Passages in A mnion Cells 
Coxsackie type 
A-9 
A-10 
A-14 
Assayed in 
0 
Amnion  7.5 
Mice  4.6 
Amnion  =< 1.5 
Mice  6.8 
Amnion  < 1.5 
Mice  6.1 
Titers* after passages in amnion 
6.8 
3.6 
n.d.:[: 
n.d. 
n.d. 
n.d. 
10 
8.2 
3.4 
5.4 
4.5 
5.0 
1.0 
8.7 
3.9 
5.2 
3.2 
6.6 
1.4 
The stored virus from amnion passages 1,  10, and 15 together with the original material 
was titrated in mice and in tube cultures from human amniotic membranes. 
* Negative log LDs0 per 0.05 ml. and TCIDs0 per 1 ml., respectively. 
n.d., not done. 
TABLE  III 
Comparative Titrations  in Amnion Cell Cultures  and in Suckling  Mice of Coxsackie 
B  Virus Strains after Passages in Cell Cultures 
Coxsackie 
type 
B-1 
B-2 
B-3 
B-4 
B-5 
A~sayed  in 
Amnion 
Mice 
Amnion 
Mice 
Amnion 
Mice 
Amnion 
Mice 
Amnion 
Mice 
Of original  After passages 
mouse  in MoK and 
passage  HeLa cell 
virus  cultures 
3.3  5.5 
6.4  5.5 
2.0  4.9 
5.4  <1.0 
7.8  8.0 
6.4  5.8 
<1.5  2.3 
6.5  5.4 
5.5  5.6 
4.0  1.4 
Titers* 
6.4 
1.5 
6.5 
<I .0 
6.6 
4.8 
<1.0 
n.d.:[: 
5.0 
<1.0 
After pas- 
sages lri 
anmion cell 
cultures 
10 
6.5 
<1.0 
6.0 
<1.0 
6.7 
4.4 
3.5 
<1.0 
6.3 
<1.0 
7.7 
<1.0 
5.9 
<1.0 
6.7 
4.8 
5.3 
<1.0 
7.3 
<1.0 
Monkey kidney prepared  viruses after passages in HeLa  and monkey kidney cells and 
amnion prepared viruses after 1,  10, and 15 passages in amnion cells together with original 
mouse passage virus were titrated in mice and in tube cultures from human amniotic mem- 
branes. 
* Negative log LDs0 per 0.02 ml. and TCIDs0 per 1 ml. 
:~ n.d., not done. 
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death  of less than  50  per  cent  of the  mice. The  most conspicuous finding  in 
the  surviving animals was  their  retarded  growth  compared with  the  control 
litter  mates.  Only  some  of  the  mice  appeared  sick,  and  occasionally  mild 
paralysis  could  be  observed.  Suckling  mice  infected  with  undiluted  10th 
amnion passage virus of Coxsackie A-11 and A-15 showed histologically isolated 
focal areas of muscle destruction  as  described  by  Gifford and  Dalldorf  (13). 
In order to gain some insight into the kinetics of this attenuation the following 
experiments were performed. 
Five additional high concentration passages were carried out in amnion cells. The stored 
suspensions from amnion passages 0 to 6, 8, 10, and 15 of A-11, A-13, A-15, and A-18 were 
titrated in suckling  mice and also in arnnion cell cultures. For A-9, A-10, and A-14 only passage 
numbers 0, 1, 10, and 15 were similarly titrated  in both host systems. 
The  results  are  presented  in  Fig.  1  and  Table II. Kinetics  of attenuation 
seem to be similar for all viruses tested. The speed, however, with which  the 
lowest levels of virulence for mice were reached differed from virus to virus. 
With  some  strains  attenuation  progressed  so  fast  that  it  became  doubtful 
whether virus which was still virulent for mice had multiplied at all in amnion. 
Inactivation rates  of these viruses at  37°C.  in  cell  culture  medium were  de- 
termined  (14).  Calculated  titers  based  on  thermal  inactivation  and  dilution 
are  included  in  Fig.  1.  A  significant  gap  between  titers  thus  expected  and 
titers  observed  indicates  that  multiplication  of  mouse  virulent  viruses  in 
amnion took place. Results with group B  viruses treated in the same manner 
are  given in  Table  III. For  comparison,  titers  obtained  with  original  mouse 
passage virus and viruses grown in MoK cells after passages in MoK and HeLa 
cell  cultures  have  been included.  The  results correspond to  those  seen  with 
group A.  Again, B-3 behaved as an exception. No attenuation  for mice with 
consecutive passages in human cells in vitro could be detected. 
Stability of attenuation was checked by passing attenuated viruses in high 
concentration in mice. Coxsackie A-11 and A-15 after 10 amnion passages and 
all 12 strains after 15 amnion passages were thus tested. Results are presented 
in Figs.  2  to 4.  While A-15, B-l, B-2, and B-5 revealed a  certain stability in 
that  they  did  not  reach  their  original  mouse  titers  after  several passages in 
mice, most group A viruses and B-4 reverted to their original levels of infec- 
tivity within  1 or  2  mouse passages. 
A-15, B-I, B-2, and B-5 were passed further in mice which led to an addi- 
tional  increase of virulence  (Fig.  5).  When  these materials were also titrated 
in  human  amnion  cell  cultures  it  was  found  that,  irrespective of low  or  in- 
creased virulence for mice, large amounts of amnion pathogenic viruses were 
produced in vivo at each passage level (Fig. 5).  Extent of CPE and infectious 
titers  for cells remained high except for B-2, for which  titers  in mice and  in 
amnion cells varied inversely. Assay in MoK cells revealed that large amounts F. LEH3~ANN-GRUBE  AND  j. T.  SYVERTON  817 
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of virus were produced in mice irrespective  of the  degree  of pathogenicity  for 
amnion  cells  or  for mice. 
These  observations  suggested  that  the  virus  preparations  contained  two 
types  of particles,  one  of high,  the  other  of low  mouse virulence.  If  this  as- 
sumption  were  true,  clonal  selection  should  lead  to  a  purified  preparation 
containing one or the other variant  only. 
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FIG. 2.  After 10 high concentration passages in amnion cells viruses were passed in new- 
born mice again. Titers  in mice as obtained with original material,  after passages in human 
amnion cells, and back passages in mice are shown. 
Clonal purification was attempted with  all viruses showing little  (A-15) or no stability 
(A-9, A-10, A-11, A-13, A-14, A-18, B-3, and B4) of attenuation when passed back in mice. 
In addition  to the  15 high concentration  passages, 5 high  dilution  passages followed by 4 
limiting dilution passages were performed as described under  Methods.  Production  of final 
(25th amnion passage) pools was done by inoculating approximately  10 TCIDs0 per ml. into 
bottle cultures. A-9 and B-3 were also 3 times plaque-purified after 15 passages at high con- 
centration,  final pools being prepared as for limiting dilution purification. 
Comparative  titrations  of  these  purified  viruses  in  amnion  cells  and  in 
suckling mice indicated further attenuation of most viruses (see Figs. 6 and 7). 
After triple plaque purifications, as compared with limiting dilution procedure, 
A-9 appeared  to be more attenuated.  Neither limiting  dilution nor picking of 
plaques significantly changed the original properties  of B-3. 
Stability  of  attenuation  after  purification  was  tested  with  A-9  (plaque- 
purified)  and A-11, A-13, and A-15 viruses. In contrast to the results obtained 
after  high  concentration  passages  only  (see  Fig.  3)  purified  viruses  shared  a 
degree of stability  (Fig.  8) similar to that seen before with B-I, B-2, and B-5. 
It  is  noteworthy  that  limiting  dilution  procedure  markedly  increased  the 
stability  of A-15 which had shown slow reversion  to virulence  after high con- F.  LEHMAIV~-GRUBE  AND  J.  T.  SYVERTON  819 
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centration passages.  Again,  a  large  amount  of amnion pathogenic virus was 
produced in the mice at each passage level, irrespective of whether virulence 
for mice slowly increased as seen with A-11,  A-13,  and A-15  or remained es- 
sentially low as with A-9. 
Neutralization of viruses with homologous immune sera was done after 10, 
15, and 25 amnion cell passages and with material from final back passages in 
mice.  In  all cases viruses were rendered non-infective after interaction with 
homologous antiserum.  It should,  however, be stressed that  minor  antigenic 
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changes  would  have  remained  undetected by the qualitative  technique  em- 
ployed. 
The dose-response curve in mice of most  Coxsackie viruses is remarkably 
steep,  extending usually  over only 2  to 3  logl0 dilution  steps.  Furthermore, 
recovery of  mice  from  Coxsackie  disease  is  exceptional.  In  contrast,  after 
attenuation  some  strains did not induce any overt signs  in mice when large 
amounts of virus had been inoculated (e.g.,  A-11, A-13, A-15,  and B-4); others 
(e.g.,  B-l,  B-2,  and  B-5)  caused  retarded  growth,  occasional paralysis,  and 
some  deaths  even  at  high  dilutions  although  undiluted  cell  culture  fluids 
killed less than  50 per cent of the inoculated animals.  The flattening of the 
dose-response curves became particularly pronounced at  intermediate  stages 
of reversion to virulence after some back passages in mice, with specific deaths 
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DISCUSSION 
Attenuation of animal  viruses for their original  host  after propagation  in 
cells in ~tro seems to  be the rule rather than  the exception. After Theiler's 
classical work with yellow fever virus which led to  the  17  D  variant  (15)  a 
variety of different agents with decreased virulence for their previous animal 
hosts have been obtained by passages in tissue or cell cultures. The viruses of 
Venezuelan  equine  encephalomyelitis  (16,  17),  fowl  plague  (18),  Newcastle 
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disease  (19,  20), Teschen disease of swine (21), West Nile virus (22),  Col SK 
strain of the encephalomyocarditis group (23), and the 3 types of polioviruses 
(24)  are examples. Attenuated variants of certain Coxsackie strains have also 
been obtained  (25-28). Continuous  passages  of Coxsackie  prototype  strains 
in human  amnion cells resulted  in  increase in  infectious titer and  degree of 
cell destruction, and a  decrease in time for the appearance of CPE in  11  out 
of 12 strains. This gain in infectivity was in all cases associated with a decreased 
pathogenicity for mice. The speed with which some strains became attenuated 
is remarkable (Fig. 1). Yet in  most cases 15 passages  employing large inocula 
did not lead  to  any degree of genetic stability.  With  the exception of A-15, 
B-I, B-2, and B-5, titers reached their original values after 1 or 2 back pas- 
sages in mice. However, limiting dilution and plaque purification changed the 824  ADAPTATION  OF  COXSACKIE  VIRUSES  TO  HU~IAN  AMN*ION  CELLS 
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pattern, and greater stability upon back passages became evident. Irrespective 
of virulence for mice as determined by infectivity titrations, large amounts of 
amnion pathogenic virus were produced in vivo. 
Although the course of adaptation and attenuation of Coxsackie viruses after 
passages in cells of primate origin can readily be recognized from our results 
not much can be said about the underlying principles which are operative. It 
is likely that a genetic mechanism is involved. The only alternative, namely a 
host-induced  change  which  has  been  shown  to  occur with  bacterial  viruses 
(29, 30) and possibly with animal viruses  (31,  32)  should lead  to phenotypic 
changes  only.  The  possibility of  a  host-induced  change  which  is  ultimately 
genotypic (33)  cannot,  however, be ruled out.  It must also be assumed  that 
adaptation of Coxsackie viruses to cells in vitro and attenuation to mice occur-- 
with the possible exception of B-2--independently of each other. Reversion to 
mouse virulence did not as a rule lead to a corresponding drop of pathogenicity 
for cells in  vitro.  There can  be little  doubt  that  the  change  in  virulence of 
Coxsackie viruses after passages in cells of primate origin is due to a qualitative 
alteration of the virus particles. The other possible explanation is that a large 
proportion of amnion infective virus is completely avirulent for mice and that 
the comparatively low titers in vivo are due to a small number of fully virulent 
mouse  particles.  The  flattened  dose-response  curves  as  obtained  with  all 
attenuated variants  strongly points  towards  a  qualitative change  (34).  That 
interference due to some factor produced in amnion cells is operative in mice 
only is unlikely because attenuated variants maintained their properties over 
several back passages in mice. Furthermore, a  limited number of experiments 
did not indicate any ability of attenuated virus produced in amnion to interfere 
with the fully virulent original agent in mice (14). 
The following hypothesis seems to explain adequately most of the observa- 
tions. The virus as it is passed and propagated in suckling mice is pathogefiic 
for mice and  to  a  much lesser degree for certain cells in  culture.  Mutations 
leading to a variant with decreased mouse pathogenicity, and increased effect 
on cells in culture, occur at a high rate. This variant which is at a competitive 
disadvantage in mice outgrows the original type in cells in vitro. 
No explanation can be offered for the genetic instability of attenuated viruses 
which  must  be inferred from the  gradual  reversion to virulence~even after 
purifying  procedures--upon  back  passage  in  mice.  Burnet  and  Lind  (35) 
found a  similar phenomenon with influenza virus.  Dulbecco and Vogt,  when 
studying the stability of poliovirus mutants which had a low plating efficiency 
under acid agar, found likewise a  stepwise reversion towards the original wild 
type (36). It is also well known that attenuated polioviruses, even after purifi- 
cation  procedures,  can  revert  to  increased  neurovirulence  following  multi- 
plication in man (37, 38) or when passed in human cells in culture (39). 
The reduced pathogenicity of the viruses for mice in spite of unaltered ability 826  ADAPTATION  OF  COXSACKIE  VIRUSES  TO  HUMAN  AMNION  CELLS 
to multiply is also unexplained as yet. It could be a  change of tissue tropism 
with shift of multiplication to organs not essential for survival. It also could 
be due to a reduced speed of multiplication in vivo, thus permitting the mouse 
to reach a  certain critical age beyond which even maximal amounts of virus 
do not cause overt paralysis, as was found by Eggers and Sabin with ECHO 9 
after passage  in  monkey kidney cells  in  culture  (40).  Experiments are  now 
planned to obtain more information about the action of attenuated Coxsackie 
viruses in mice. 
In view of the recent discussion in the literature concerning classification of 
the  group  of  enteroviruses,  our  findings  are  significant.  It  seems  that  any 
classification based  solely or mainly on  the host  spectrum of  the  agent  can 
lead to conclusions not always justified, if its previous history--in nature  or 
in the laboratory--can be suspected to have altered the host spectrum.  It is 
possible that some of the Coxsackie viruses, if tested in mice after isolation and 
p~ssages in cell culture, would have been classified as ECHO types. A similar 
confusion might have resulted as it now exists with ECHO 9, whose unexpected 
mouse pathogenicity led to  attempts to reclassify the Coxsackie and  ECHO 
viruses (41, 42). Probably for such reasons, in the discussions on nomenclature 
at  the Fifth International  Congress  of Microbiology held in  1950  at  Rio  de 
Janeiro, there was "unanimous" opinion that "symptoms produced in the host 
should,  with emphasis,  be placed at the bottom" of the list of criteria to be 
applied in  classifying viruses  (43). 
SUMMARY 
Continuous passages  in primary human  amnion cell cultures of Coxsackie 
prototype viruses A-9, A-10, A-11, A-13,  A-14, A-15, A-18,  B-l, B-2, B-4, and 
B-5  increased  the  titers,  hastened  and  enhanced  cytopathic  effect,  and  in 
varying degrees caused loss of virulence for newborn mice. Only B-3 behaved 
differently in  that  neither  adaptation  to  cells in  vitro  nor attenuation  with 
respect to the original animal host could be observed. Types A-15,  B-l, B-2, 
and B-5 slowly regained virulence when passed in mice after high concentration 
passages  in  amnion  cells whereas  all  other viruses reverted to  their original 
virulence after only 1 or 2 passages  in the animal host.  When these strains, 
however,  were  purified  by  cloning  procedures,  they  too  showed  markedly 
increased stability. In all stages of attenuation, viruses multiplied extensively 
in vivo as could be shown by titration in amnion cell cultures. It is suggested 
that  a  genetic mechanism is operative leading to virus populations in  which 
the majority of the particles is qualitatively changed. 
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